肺水肿市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00017663
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

预计肺水肿市场在 2024 年至 2031 年期间的复合年增长率为 8.4%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

肺水肿市场规模和预测(2021-2031 年)、全球和区域份额、趋势和增长机会分析报告范围:按:类型(心脏相关性肺水肿、非心脏相关性肺水肿);诊断类型(胸部 X 光、脉搏血氧饱和度、血液测试、影像等);治疗(预负荷减少剂、后负荷减少剂、心脏药物、吗啡、抽吸导管等);最终用户(医院、诊所、诊断中心、零售药店等)和地理区域(北美、欧洲、亚太地区以及南美洲和中美洲)

报告目的

The Insight Partners 撰写的《肺水肿市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

肺水肿市场细分

 

类型

  • 心脏相关肺水肿
  • 非心脏相关性肺水肿

诊断类型

  • 胸部 X 光检查
  • 脉搏血氧测定
  • 验血
  • 影像及其他

治疗

  • 预紧减速器
  • 减载器后
  • 心脏药物
  • 吗啡
  • 吸痰管
  • 其他的

终端用户

  • 医院
  • 诊所
  • 诊断中心
  • 零售药店
  • 其他的

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

肺水肿市场:战略洞察

Pulmonary Edema Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

肺水肿市场增长动力

  • 乳腺癌发病率不断上升:全球化和经济增长进一步加剧了发展中国家(64% 至 95%)和发达国家(32% 至 56%)的乳腺癌发病率。乳腺癌是印度最常见的癌症,占所有女性癌症的 28.2%,预计到 2022 年将有 216,108 例
  • 女性酒精消费量不断上升:在印度,女性酒精消费量不断上升,因此必须注意这一风险。超重或肥胖,尤其是绝经后,会增加患乳腺癌的风险。乳腺癌是全球第二大常见癌症。它是女性中排名第一的癌症。
  • 技术进步- 各种在早期发现癌症的技术进步正在促进增长。这些包括对标准技术(乳房X光检查、超声波和MRI)的改进,以及从身体成像工具开发的新乳房成像平台,其中包括CT和放射性核素乳房成像。

肺水肿市场未来趋势

  • 电离乳腺成像技术:医疗辐射以及日本原子弹等大规模灾难表明,辐射可导致乳腺癌。电离辐射是任何形式的辐射,其能量足以改变原子,例如 X 射线或核能
  • 人工智能的加入:诊断治疗学是一种目前尚未开发的核医学疗法,但将成为未来乳腺放射科医生的重要工具。人工智能辅助影像诊断为乳腺癌提供了更准确、更高效的诊断模型,前景光明。人工智能系统经过数千张去识别的乳房X光片的训练。
  • 数字乳腺断层合成:数字乳腺断层合成筛查检查,也称为 3D 乳房 X 线摄影,已成为女性健康领域乳腺癌检测技术的最佳实践。乳腺断层合成与传统乳房 X 线摄影的不同之处在于获取和查看乳房图像的方式。

肺水肿市场机会

  • 新兴国家的增长潜力:印度、中国、巴西、俄罗斯、韩国和土耳其等国家拥有庞大的人口基数,这将刺激诊断成像设备市场的增长。中国建议 30 岁起患有 BRCA 种系突变的女性每年进行乳房 X 线摄影和 MRI 筛查。
  • 针对乳腺癌采取的举措:UICC 的乳腺癌计划旨在支持和加强主要乳腺癌行动者的能力,以增加其影响力,特别关注中低收入国家,并支持实现 GBCI 的目标。世卫组织于 2021 年成立的全球乳腺癌倡议将为各国政府提供加强乳腺癌卫生系统的指导。
  • 乳腺癌基金:Komen 提供资助,支持为患者带来最大益处的尖端乳腺癌研究。乳腺癌研究基金会的使命是通过推进世界上最有前景的乳腺癌研究来预防和治疗乳腺癌

 

肺水肿市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响肺水肿市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的肺水肿市场细分和地理位置。

Pulmonary Edema Market
  • 获取肺水肿市场的区域特定数据

肺水肿市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2025 - 2031)8.4%
史料2021-2023
预测期2025-2031
涵盖的领域按类型
  • 心脏相关肺水肿
  • 非心脏相关性肺水肿
按诊断类型
  • 胸部 X 光检查
  • 脉搏血氧测定
  • 验血
  • 影像及其他
按治疗
  • 预紧减速器
  • 减载器后
  • 心脏药物
  • 吗啡
  • 吸痰管
  • 其他的
按最终用户
  • 医院
  • 诊所
  • 诊断中心
  • 零售药店
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 辉瑞公司,
  • 氩医疗
  • 爱德华生命科学公司
  • 屋宇署
  • 鲁宾制药公司
  • 诺华公司
  • 吉利德科学公司
  • 默克公司
  • 爵士制药公司

 

肺水肿市场参与者密度:了解其对业务动态的影响

肺水肿市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在肺水肿市场运营的主要公司有:

  1. 辉瑞公司,
  2. 氩医疗
  3. 爱德华生命科学公司
  4. 屋宇署
  5. 鲁宾制药公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Pulmonary Edema Market

 

  • 了解肺水肿市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了肺水肿市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,肺水肿市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
pulmonary-edema-market-report-deliverables-img1
pulmonary-edema-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


Which region is expected to register highest growth during the forecast period?

Asia pacific region is expected to witness the highest growth during the forecast period

Which country held the second largest share in Europe in 2023?

In Europe, the UK held the second largest share in 2023.

Which region held the largest share in 2023?

North America held the largest share in 2023 and is expected to retain its dominance during the forecast period

What is the expected CAGR of the Pulmonary Edema Market?

The Pulmonary Edema Market is estimated to witness a CAGR of 8.4% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Pfizer Inc.,
2. Argon Medical
3. Edward Lifesciences Corporation
4. BD
5. Lupin Pharmaceuticals Inc.
6. Novartis AG
7. Gilead Sciences Inc.
8. Merck & Co
9. Jazz Pharmaceuticals Plc
10. Sage Therapeutics
pulmonary-edema-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.